"MEDCHEMEXPRESS"
MEDCHEM EXPRESS SLX 2119 ROCK INHIBITOR KD-025 1 * 5 mg
Supplier: MEDCHEMEXPRESS
MEDCHEM EXPRESS SLX 2119 ROCK INHIBITOR KD-025 1 * 5 mg
Expand 1 Items
MEDCHEMEXPRESS T-5224 10MM 1 * 10 mg
Supplier: MEDCHEMEXPRESS
MEDCHEMEXPRESS T-5224 10MM 1 * 10 mg
Expand 1 Items
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO ≥125MG/ML WATER <1.2MG/ML ETHANOL ≥124MG/ML
PHA-665752 IS A POTENT, SELECTI VE AND ATP-COMPETITIVE C-MET INHIBITOR WITH IC50 OF 9 NM, >50-FOLD SELECTIVITY FOR C-MET THAN RTKS OR STKS.IC50 VALUE 1 * 10 mg
Supplier: MEDCHEMEXPRESS
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO ≥125MG/ML WATER <1.2MG/ML ETHANOL ≥124MG/ML
PHA-665752 IS A POTENT, SELECTI VE AND ATP-COMPETITIVE C-MET INHIBITOR WITH IC50 OF 9 NM, >50-FOLD SELECTIVITY FOR C-MET THAN RTKS OR STKS.IC50 VALUE 1 * 10 mg
Expand 1 Items
LY294002 [154447-36-6] 1 * 10 mg
Supplier: MEDCHEMEXPRESS
LY294002 [154447-36-6] 1 * 10 mg
Expand 1 Items
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO 65 MG/ML WATER 65 MG/ML
Y-27632 2HCL IS A SELECTIVE ROCK1 (P160ROCK) INHIB ITOR WITH KI OF 140 NM, EXHIBITS >200-FOLD SELECTIVITY OVER OTHER KINASES, INCLUDING PKC, CAMP-DEPENDENT PROTEIN KINA 1 * 50 mg
Supplier: MEDCHEMEXPRESS
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO 65 MG/ML WATER 65 MG/ML
Y-27632 2HCL IS A SELECTIVE ROCK1 (P160ROCK) INHIB ITOR WITH KI OF 140 NM, EXHIBITS >200-FOLD SELECTIVITY OVER OTHER KINASES, INCLUDING PKC, CAMP-DEPENDENT PROTEIN KINA 1 * 50 mg
Expand 1 Items
SOLUBILITY: 10 MM IN DMSO
FUMARATE HYDRATASE-IN-1, AN ENZYME OF THE TCA CYCLE. INHIBITION OF FUMARATE HYDRATASE-IN-1 CAN CONTRIBU TE TO TUMORIGENICITY IN SOME CELLS. THE USE OF A PHOTOAFFINITY LABELING STRATEGY IDENTIFIED FUMARATE HYDRATASE AS THE 1 * 1 mL
Supplier: MEDCHEMEXPRESS
SOLUBILITY: 10 MM IN DMSO
FUMARATE HYDRATASE-IN-1, AN ENZYME OF THE TCA CYCLE. INHIBITION OF FUMARATE HYDRATASE-IN-1 CAN CONTRIBU TE TO TUMORIGENICITY IN SOME CELLS. THE USE OF A PHOTOAFFINITY LABELING STRATEGY IDENTIFIED FUMARATE HYDRATASE AS THE 1 * 1 mL
Expand 1 Items
MRT68921 DIHYDROCHLORIDE 1 * 50 mg
Supplier: MEDCHEMEXPRESS
MRT68921 DIHYDROCHLORIDE 1 * 50 mg
Expand 1 Items
SOLUBILITY: DMSO ≥45MG/ML WATER <1.2MG/ML ETHANOL <1.2.MG/ML
VELIPARIB (ABT-888) IS A POTENT INHIBITOR OF PARP1 AND PARP2 WITH KI OF 5.2 NM AND 2.9 NM, RESPECTIVELY.IC50 VALUE: 5.2 NM(KI FOR PARP1) 2.9 NM(KI FOR PARP2) [1]TARGET: PARP1 PARP2IN I 1 * 50 mg
Supplier: MEDCHEMEXPRESS
SOLUBILITY: DMSO ≥45MG/ML WATER <1.2MG/ML ETHANOL <1.2.MG/ML
VELIPARIB (ABT-888) IS A POTENT INHIBITOR OF PARP1 AND PARP2 WITH KI OF 5.2 NM AND 2.9 NM, RESPECTIVELY.IC50 VALUE: 5.2 NM(KI FOR PARP1) 2.9 NM(KI FOR PARP2) [1]TARGET: PARP1 PARP2IN I 1 * 50 mg
Expand 1 Items
SOLUBILITY: SOLUBLE TO 100 MM IN DMSO AND TO 100 MM IN ETHANOL
CALCIPOTRIOL, A 1,25-DIHYDROXYVITAMIN D3 ANALOGUE, IS USED AS TOPI CAL TREATMENT FOR PSORIASIS.IC50 VALUE: TARGET: VITAMIN D3 ANALOGUEIN VITRO: CALCIPOTRIOL INCREASED HCAP18 MRNA EXPRE 1 * 5 mg
Supplier: MEDCHEMEXPRESS
SOLUBILITY: SOLUBLE TO 100 MM IN DMSO AND TO 100 MM IN ETHANOL
CALCIPOTRIOL, A 1,25-DIHYDROXYVITAMIN D3 ANALOGUE, IS USED AS TOPI CAL TREATMENT FOR PSORIASIS.IC50 VALUE: TARGET: VITAMIN D3 ANALOGUEIN VITRO: CALCIPOTRIOL INCREASED HCAP18 MRNA EXPRE 1 * 5 mg
Expand 1 Items
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO ≥10MG/ML WATER <1.2MG/ML ETHANOL <1.2MG/ML
NILOTINIB (AMN-107) IS A BCR-ABL INHIBITOR WITH IC50 LESS THAN 30 NM.IC50 VALUE: < 30 NM [1]TARGET: BCR-ABLIN VITRO: NILOTINIB (AMN107) IS SIGNIFICAN 1 * 100 mg
Supplier: MEDCHEMEXPRESS
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO ≥10MG/ML WATER <1.2MG/ML ETHANOL <1.2MG/ML
NILOTINIB (AMN-107) IS A BCR-ABL INHIBITOR WITH IC50 LESS THAN 30 NM.IC50 VALUE: < 30 NM [1]TARGET: BCR-ABLIN VITRO: NILOTINIB (AMN107) IS SIGNIFICAN 1 * 100 mg
Expand 1 Items
SOLUBILITY: DMSO: ≥ 34 MG/ML
OLAPARIB (AZD2281, KU0059436) IS A POTENT PARP INHIBITOR WITH IC50 OF 5 AND 1 NM FOR PARP-1AND PARP- 2, RESPECTIVELY.IC50 VALUE: 5 NM(PARP-1) 1 NM(PARP-2)TARGET: PARPIN VITRO: OLAPARIB WOULD ACT AGAINST BRCA1 OR BRCA2 1 * 100 mg
Supplier: MEDCHEMEXPRESS
SOLUBILITY: DMSO: ≥ 34 MG/ML
OLAPARIB (AZD2281, KU0059436) IS A POTENT PARP INHIBITOR WITH IC50 OF 5 AND 1 NM FOR PARP-1AND PARP- 2, RESPECTIVELY.IC50 VALUE: 5 NM(PARP-1) 1 NM(PARP-2)TARGET: PARPIN VITRO: OLAPARIB WOULD ACT AGAINST BRCA1 OR BRCA2 1 * 100 mg
Expand 1 Items
SOLUBILITY: DMSO: ≥ 34 MG/ML
OLAPARIB (AZD2281, KU0059436) IS A POTENT PARP INHIBITOR WITH IC50 OF 5 AND 1 NM FOR PARP-1AND PARP- 2, RESPECTIVELY.IC50 VALUE: 5 NM(PARP-1) 1 NM(PARP-2)TARGET: PARPIN VITRO: OLAPARIB WOULD ACT AGAINST BRCA1 OR BRCA2 1 * 1 mL
Supplier: MEDCHEMEXPRESS
SOLUBILITY: DMSO: ≥ 34 MG/ML
OLAPARIB (AZD2281, KU0059436) IS A POTENT PARP INHIBITOR WITH IC50 OF 5 AND 1 NM FOR PARP-1AND PARP- 2, RESPECTIVELY.IC50 VALUE: 5 NM(PARP-1) 1 NM(PARP-2)TARGET: PARPIN VITRO: OLAPARIB WOULD ACT AGAINST BRCA1 OR BRCA2 1 * 1 mL
Expand 1 Items
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO ≥90MG/ML WATER <1.2MG/ML ETHANOL ≥30MG/ML
DANUSERTIB (PHA-739358) IS A PYRR OLO-PYRAZOLE AND SMALL MOLECULE AURORA KINASES INHIBITOR WITH IC50 OF 13, 79, AND 61 NM FOR AURORA A, B, AND C, RESPE 1 * 5 mg
Supplier: MEDCHEMEXPRESS
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO ≥90MG/ML WATER <1.2MG/ML ETHANOL ≥30MG/ML
DANUSERTIB (PHA-739358) IS A PYRR OLO-PYRAZOLE AND SMALL MOLECULE AURORA KINASES INHIBITOR WITH IC50 OF 13, 79, AND 61 NM FOR AURORA A, B, AND C, RESPE 1 * 5 mg
Expand 1 Items
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO ≥90MG/ML WATER <1.2MG/ML ETHANOL <1.2MG/ML
MLN8054 IS A POTENT AND SELECTIV E INHIBITOR OF AURORA A WITH IC50 OF 4 NM EXHIBITS MORE THAN 40-FOLD SELECTIVE FOR AURORA A THAN AURORA B.IC50 VALUE 1 * 10 mg
Supplier: MEDCHEMEXPRESS
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO ≥90MG/ML WATER <1.2MG/ML ETHANOL <1.2MG/ML
MLN8054 IS A POTENT AND SELECTIV E INHIBITOR OF AURORA A WITH IC50 OF 4 NM EXHIBITS MORE THAN 40-FOLD SELECTIVE FOR AURORA A THAN AURORA B.IC50 VALUE 1 * 10 mg
Expand 1 Items
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO: ＞ 5.1 MG/ML, H2O: ＜ 1 MG/ML
CHIR-99021 (CT99021) IS A GSK-3Α/Β INHIBITOR W ITH IC50 OF 10 NM/6.7 NM > 500-FOLD SELECTIVITY FOR GSK-3 VERSUS ITS CLOSEST HOMOLOGS CDC2 AND ERK2, AS WELL AS OTHE 1 * 10 mg
Supplier: MEDCHEMEXPRESS
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO: ＞ 5.1 MG/ML, H2O: ＜ 1 MG/ML
CHIR-99021 (CT99021) IS A GSK-3Α/Β INHIBITOR W ITH IC50 OF 10 NM/6.7 NM > 500-FOLD SELECTIVITY FOR GSK-3 VERSUS ITS CLOSEST HOMOLOGS CDC2 AND ERK2, AS WELL AS OTHE 1 * 10 mg
Expand 1 Items
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO: ＞ 5.1 MG/ML, H2O: ＜ 1 MG/ML
CHIR-99021 (CT99021) IS A GSK-3Α/Β INHIBITOR W ITH IC50 OF 10 NM/6.7 NM > 500-FOLD SELECTIVITY FOR GSK-3 VERSUS ITS CLOSEST HOMOLOGS CDC2 AND ERK2, AS WELL AS OTHE 1 * 50 mg
Supplier: MEDCHEMEXPRESS
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO: ＞ 5.1 MG/ML, H2O: ＜ 1 MG/ML
CHIR-99021 (CT99021) IS A GSK-3Α/Β INHIBITOR W ITH IC50 OF 10 NM/6.7 NM > 500-FOLD SELECTIVITY FOR GSK-3 VERSUS ITS CLOSEST HOMOLOGS CDC2 AND ERK2, AS WELL AS OTHE 1 * 50 mg